Veena Rajashekara | MolecularCloud

Veena Rajashekara

Veena is associated with 21st Century Health Analytics Pte Ltd as Scientist – Research Insights. She has 8+ years of experience in life science research including oncology, neurodegeneration and gut microbiome. Presently, working on implications of gut microbiome on human health and diseases converging on developing a product for risk assessment based on individual’s gut microbial composition. She is highly skilled in precision medicine – oncology and possesses sound knowledge of cancer network and drugs, immune-oncology, cell and molecular biology. She has been actively working in oncology research for more than 5 years and has been associated with one of the world’s leaders in precision medicine. Her expertise also includes neurodegenerative disorders and the impact of physical exercise and social enrichment in ameliorating neuro degeneration. Veena is now associated with MolecularCloud platform as a scientific writer and is here to share knowledge/views on current trends in life science research.

Lab Information

21st Century Health Analytics Pte Ltd

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Cancer/oncology 0 Precision Medicine 0 Gut microbiome 0 Neurodegeneration 0

Post
Publication
Plasmid
Following (0)
Follower (2)

Precision Medicine Immuno-oncology – Harnessing immune s ...

Veena Rajashekara 09:07:10 08/03/2020

Veena Rajashekara 21st Century Health Analytics Pte Ltd

Post

Follower

The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More

Precision Medicine – A revolution in cancer therapy

Veena Rajashekara 20:31:08 07/08/2020

Veena Rajashekara 21st Century Health Analytics Pte Ltd

Post

Follower

Precision medicine is an evolving therapeutic approach in health care industry, particularly for cancer care. Recently, this approach is also being considered for neurodegenerative diseases and other rare diseases. Though, focus of this article is Precision medicine – ...Learn More

Cloud Scientists

Nathan Hillson

Lawrence Berkeley National Laboratory
1 Followed
Benjamin Kleinstiver

The Kleinstiver Lab
1 Followed
Caixia Gao

Institute of Genetics and Developmental Biology, Chinese Academy of Sciences
1 Followed

View all